Yu K - Search Results

1

Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.

Qian F, Yang W, Wang R, Xu J, Wang S, Zhang Y, Jin B, Yu K, Han B. Qian F, et al. Among authors: yu k. J Thorac Cardiovasc Surg. 2018 Mar;155(3):1227-1235.e2. doi: 10.1016/j.jtcvs.2017.09.143. Epub 2017 Nov 7. J Thorac Cardiovasc Surg. 2018. PMID: 29223834 Free article.

2

Surgical Therapy for Bilateral Multiple Primary Lung Cancer.

Yang H, Sun Y, Yao F, Yu K, Gu H, Han B, Zhao H. Yang H, et al. Among authors: yu k. Ann Thorac Surg. 2016 Mar;101(3):1145-52. doi: 10.1016/j.athoracsur.2015.09.028. Epub 2015 Nov 18. Ann Thorac Surg. 2016. PMID: 26602007

3

MDC and BLC are independently associated with the significant risk of early stage lung adenocarcinoma.

Zhang Y, Yu K, Hu S, Lou Y, Liu C, Xu J, Li R, Zhang X, Wang H, Han B. Zhang Y, et al. Among authors: yu k. Oncotarget. 2016 Dec 13;7(50):83051-83059. doi: 10.18632/oncotarget.13031. Oncotarget. 2016. PMID: 27811371 Free PMC article.

4

Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.

Wang S, Xu J, Wang R, Qian F, Yang W, Qiao R, Zhang B, Qian J, Yu K, Han B. Wang S, et al. Among authors: yu k. J Thorac Cardiovasc Surg. 2018 Nov;156(5):2006-2015.e2. doi: 10.1016/j.jtcvs.2018.06.034. Epub 2018 Jul 18. J Thorac Cardiovasc Surg. 2018. PMID: 30104070 Free article.

5

Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations.

Zhang Y, Xu J, Lou Y, Hu S, Yu K, Li R, Zhang X, Jin B, Han B. Zhang Y, et al. Among authors: yu k. Int J Cancer. 2017 Apr 1;140(7):1645-1652. doi: 10.1002/ijc.30581. Epub 2017 Jan 12. Int J Cancer. 2017. PMID: 28006834

6

High-resolution Computed Tomography Features Distinguishing Benign and Malignant Lesions Manifesting as Persistent Solitary Subsolid Nodules.

Yang W, Sun Y, Fang W, Qian F, Ye J, Chen Q, Jiang Y, Yu K, Han B. Yang W, et al. Among authors: yu k. Clin Lung Cancer. 2018 Jan;19(1):e75-e83. doi: 10.1016/j.cllc.2017.05.023. Epub 2017 Jun 8. Clin Lung Cancer. 2018. PMID: 28822623

7

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma.

Zhang J, Shao J, Zhu L, Zhao R, Xing J, Wang J, Guo X, Tu S, Han B, Yu K. Zhang J, et al. Among authors: yu k. Oncotarget. 2017 Aug 24;8(43):74846-74855. doi: 10.18632/oncotarget.20420. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088828 Free PMC article.

8

Establishment and management of a lung cancer biobank in Eastern China.

Yu K, Zhang J, Li X, Xu L, Zhang Y, Xing J, Shao J, Zhu L, Liu J, Zhao L, Han B. Yu K, et al. Thorac Cancer. 2015 Jan;6(1):58-63. doi: 10.1111/1759-7714.12144. Epub 2015 Jan 7. Thorac Cancer. 2015. PMID: 26273336 Free PMC article.

9

Gprc5a-knockout mouse lung epithelial cells predicts ceruloplasmin, lipocalin 2 and periostin as potential biomarkers at early stages of lung tumorigenesis.

Sun B, Guo W, Hu S, Yao F, Yu K, Xing J, Wang R, Song H, Liao Y, Wang T, Jiang P, Han B, Deng J. Sun B, et al. Among authors: yu k. Oncotarget. 2017 Feb 21;8(8):13532-13544. doi: 10.18632/oncotarget.14589. Oncotarget. 2017. PMID: 28088789 Free PMC article.

10

Screening anlotinib responders via blood-based proteomics in non-small cell lung cancer.

Lu J, Zhang W, Yu K, Zhang L, Lou Y, Gu P, Nie W, Qian J, Xu J, Wang H, Zhong H, Han B. Lu J, et al. Among authors: yu k. FASEB J. 2022 Aug;36(8):e22465. doi: 10.1096/fj.202101658R. FASEB J. 2022. PMID: 35867072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,405 results

Search Page

Filters